S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aptose BiosciencesSolid BiosciencesInnate PharmaJounce TherapeuticsCASI Pharmaceuticals
SymbolNASDAQ:APTONASDAQ:SLDBOTCMKTS:IPHYFNASDAQ:JNCENASDAQ:CASI
Price Information
Current Price$3.71$8.83$4.53$11.45$2.18
52 Week RangeBuyBuyBuyHoldBuy
MarketRank™
Overall Score1.41.10.61.41.5
Analysis Score3.51.30.02.23.5
Community Score2.72.62.82.72.5
Dividend Score0.00.00.00.00.0
Ownership Score0.80.80.01.70.8
Earnings & Valuation Score0.00.60.00.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$11.63$7.13N/A$14.00$4.25
% Upside from Price Target213.34% upside-19.31% downsideN/A22.27% upside94.95% upside
Trade Information
Market Cap$329.60 million$533.77 million$355.79 million$519.76 million$270.20 million
Beta1.621.11.061.340.41
Average Volume1,016,9691,292,7213,111532,836503,281
Sales & Book Value
Annual RevenueN/AN/A$96.12 million$147.87 million$4.13 million
Price / SalesN/AN/A3.703.5165.42
CashflowN/AN/AN/A$2.79 per shareN/A
Price / CashN/AN/AN/A4.11N/A
Book Value$1.23 per share$1.74 per share$4.23 per share$5.25 per share$0.76 per share
Price / BookN/AN/A1.072.182.87
Profitability
Net Income$-26,280,000.00$-117,220,000.00$-23,250,000.00$56.82 million$-46,030,000.00
EPS($0.52)($2.91)N/A$1.66($0.42)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/A-402.87%
Return on Equity (ROE)-49.53%-194.22%N/A-72.91%-60.96%
Return on Assets (ROA)-46.65%-140.40%N/A-59.68%-42.48%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.03%N/AN/AN/A
Current Ratio24.60%1.84%1.99%6.60%14.99%
Quick Ratio24.60%1.84%N/A6.60%14.86%
Ownership Information
Institutional Ownership Percentage52.22%42.73%N/A60.48%31.95%
Insider Ownership Percentage6.30%31.20%N/A43.96%24.75%
Miscellaneous
Employees31121247129125
Shares Outstanding88.84 million60.45 million78.54 million45.39 million123.94 million
Next Earnings Date3/23/2021 (Confirmed)3/11/2021 (Estimated)3/9/2021 (Estimated)5/5/2021 (Estimated)3/15/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.